What is ProteanTecs?
ProteanTecs operates at the forefront of the electronics industry, providing sophisticated on-chip monitoring and predictive analytics solutions. Its technology enables enhanced visibility, reliability, and performance optimization throughout the entire chip lifecycle. By leveraging deep data insights and advanced machine learning algorithms, ProteanTecs addresses critical challenges in chip design, manufacturing, and operation, positioning itself as a key player in ensuring the integrity and efficiency of modern electronic systems.
How much funding has ProteanTecs raised?
ProteanTecs has raised a total of $191M across 5 funding rounds:
Series A
$10M
Series B
$35M
Series C
$50M
Other Financing Round
$45M
Series D
$51M
Series A (2017): $10M, investors not publicly disclosed
Series B (2019): $35M, investors not publicly disclosed
Series C (2020): $50M supported by Valor Equity Partners, Koch, and Atreides Management
Other Financing Round (2022): $45M featuring Porsche SE, Advantest, MediaTek, and Koch Disruptive Technologies
Series D (2025): $51M backed by Siemens, Samsung Catalyst Fund, and IAG Capital Partners
Key Investors in ProteanTecs
Porsche SE
Porsche SE is a holding company with significant investments in mobility and industrial technology, notably holding a majority stake in Volkswagen AG, indicating a strategic interest in automotive and related technological advancements.
Advantest
Advantest, a long-standing manufacturer of automatic test equipment for semiconductors, brings deep industry expertise and a focus on the testing and validation aspects of electronic components.
Samsung Catalyst Fund
Samsung Catalyst Fund is a venture capital arm focused on deep-tech infrastructure and data-enabled platforms, suggesting a strategic alignment with ProteanTecs' advanced analytics and machine learning capabilities.
What's next for ProteanTecs?
The recent major strategic investment signals a strong validation of ProteanTecs' technological advancements and market potential. This influx of capital is expected to fuel further research and development, expand its market reach, and enhance its predictive analytics capabilities. As the company continues to scale, it is poised to deepen its impact on the electronics sector, offering solutions that are increasingly vital for complex, high-performance systems. The enterprise-level funding context suggests ProteanTecs is in a growth phase, likely focusing on expanding its customer base and solidifying its position as an industry leader in chip lifecycle management.
See full ProteanTecs company page
